Want to see LFVN full AI Analyst Report?
LFVN Stock Chart & Stats
$6.76
$4.55(27.66%)
At close: 4:00 PM EST
$6.76
$4.55(27.66%)
Day’s Range― - ―
52-Week Range$3.90 - $15.00
Previous CloseN/A
Volume441.49K
Average Volume (3M)676.44K
Market Cap
$78.47M
Enterprise Value$74.17M
Total Cash (Recent Filing)$12.48M
Total Debt (Recent Filing)$10.21M
Price to Earnings (P/E)13.5
Beta0.13
Next Earnings
Aug 25, 2026EPS Estimate
0.13Next Dividend Ex-DateN/A
Dividend Yield2.81%
Share Statistics
EPS (TTM)0.46
Shares Outstanding12,615,822
10 Day Avg. Volume902,233
30 Day Avg. Volume676,440
Financial Highlights & Ratios
PEG Ratio0.07
Price to Book (P/B)4.63
Price to Sales (P/S)0.70
P/FCF Ratio15.25
Enterprise Value/Market Cap0.95
Enterprise Value/Revenue0.38
Enterprise Value/Gross Profit0.49
Enterprise Value/Ebitda7.73
Forecast
1Y Price Target
$5.00Price Target Upside-26.04% Downside
Rating ConsensusHold
Number of Analyst Covering1
EPS Forecast (FY)0.53
Revenue Forecast (FY)$179.84M
Bulls Say, Bears Say
Bulls Say
High Gross MarginsLifeVantage's ~79% gross margin across supplements and skincare establishes durable unit economics. Strong gross profit cushions operating spend and channel incentives, enabling reinvestment in e-commerce and product development while helping absorb cost pressures during volume fluctuations.
Strong Liquidity & Low LeverageWith $12.5M cash, no debt and an improving leverage profile, the company has meaningful financial flexibility to fund strategic initiatives, acquisitions, dividend increases and buybacks. Low leverage reduces refinancing risk and supports stability through cyclical revenue swings.
Product & Portfolio ExpansionAcquiring LoveBiome and integrating P84 plus a granted U.S. patent broaden the product portfolio and introduce differentiated IP. These moves expand addressable markets (gut-health trends) and strengthen product-driven growth potential, important for sustaining distributor engagement and repeat sales.
Bears Say
Revenue Decline And Field SoftnessA 25% YoY revenue drop and sequential declines in active consultants in the Americas indicate weakening core distributor-driven demand. In a network-marketing model, persistent declines in active accounts and customer activity materially erode recurring revenue and make recovery dependent on structural field reactivation initiatives.
Weakened Cash ConversionCash generation has become uneven: free cash flow is only ~58% of net income TTM and operating cash flow relative to revenue is modest. This inconsistent cash conversion constrains the firm's ability to reliably fund marketing, capital projects or shareholder returns if revenue weakness persists.
Profitability Compression & Operating LeverageMargins have compressed materially with adjusted EBITDA falling to 7.3% and SG&A rising as a percent of sales; commissions remain a large share of revenue. High variable commission costs coupled with fixed overhead amplify operating leverage, risking further margin deterioration during lower sales periods.
LifeVantage News
LFVN FAQ
What was LifeVantage Corp’s price range in the past 12 months?
LifeVantage Corp lowest stock price was $3.90 and its highest was $15.00 in the past 12 months.
What is LifeVantage Corp’s market cap?
LifeVantage Corp’s market cap is $78.47M.
When is LifeVantage Corp’s upcoming earnings report date?
LifeVantage Corp’s upcoming earnings report date is Aug 25, 2026 which is in 52 days.
How were LifeVantage Corp’s earnings last quarter?
LifeVantage Corp released its earnings results on May 06, 2026. The company reported $0.12 earnings per share for the quarter, missing the consensus estimate of $0.157 by -$0.037.
Is LifeVantage Corp overvalued?
According to Wall Street analysts LifeVantage Corp’s price is currently Overvalued.
Does LifeVantage Corp pay dividends?
LifeVantage Corp pays a Quarterly dividend of $0.05 which represents an annual dividend yield of 2.81%. See more information on LifeVantage Corp dividends here
What is LifeVantage Corp’s EPS estimate?
LifeVantage Corp’s EPS estimate is 0.13.
How many shares outstanding does LifeVantage Corp have?
LifeVantage Corp has 12,615,822 shares outstanding.
What happened to LifeVantage Corp’s price movement after its last earnings report?
LifeVantage Corp reported an EPS of $0.12 in its last earnings report, missing expectations of $0.157. Following the earnings report the stock price went down -16.323%.
Which hedge fund is a major shareholder of LifeVantage Corp?
Currently, no hedge funds are holding shares in LFVN
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
LifeVantage Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Hold
Average Price Target:
$5.00 (-26.04% Downside)
$5.00 (-26.04% Downside)
Hedge Fund Trend
Decreased
By 10.9K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Sold Shares
Worth $79.3K over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Very Positive
Last 7 Days ▼ 5.1%
Last 30 Days ▲ 33.5%
Last 30 Days ▲ 33.5%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Positive
20 days / 200 days
Momentum
-52.33%
12-Months-Change
Fundamentals
Return on Equity
17.78%
Trailing 12-Months
Asset Growth
-19.56%
Trailing 12-Months
Company Description
LifeVantage Corp
LifeVantage Corporation (LFVN) specializes in the development, manufacture, and distribution of a diverse portfolio of health, wellness, and personal care products. Its offerings encompass nutrigenomic activators (designed to influence genetic expression), a broad array of dietary supplements, cognitive enhancers (nootropics), gut health support (pre- and pro-biotics), weight management solutions, and various personal care items spanning skin care, hair care, bath and body, and targeted relief. The company's product lineup features well-known brands such as Protandim, a series of scientifically validated dietary supplements. Specific examples include LifeVantage Omega+, a blend of DHA/EPA Omega-3s, Omega-7s, and Vitamin D3; LifeVantage ProBio, designed for digestive wellness; the PhysIQ brand for weight management; Petandim, tailored to reduce oxidative stress in dogs; and Axio energy drink mixes. Under the TrueScience brand, LifeVantage also provides anti-aging skincare (e.g., facial cleansers, perfecting lotions, eye serums, creams), hair care solutions (e.g., invigorating shampoos, nourishing conditioners, scalp serums), and an assortment of bath and body products (e.g., body lotion, wash, butter, deodorant) and targeted relief items (e.g., soothing balm, body rub). Distribution occurs through both its proprietary website and an extensive network of independent distributors. LifeVantage maintains a significant international presence, with operations spanning numerous global territories including the United States, Mexico, Japan, Australia, Hong Kong, Canada, Thailand, the United Kingdom, the Netherlands, Germany, Taiwan, Austria, Spain, Ireland, Belgium, New Zealand, Singapore, and China. The corporation's headquarters are situated in Lehi, Utah.
LFVN Earnings Call
Q3 2026
0:00 / 0:00
Earnings Call Sentiment|Neutral
The call communicated a mixed picture: meaningful near-term financial headwinds with a 25.2% revenue decline, reduced profitability, and lower cash flow are offset by solid liquidity (no debt and $12.5M cash), active shareholder returns (buybacks and increased dividend), a newly granted patent, strategic acquisition (LoveBiome/P84), investments in Shopify and digital infrastructure, stronger field engagement initiatives (Momentum Academy and VIP program), and the appointment of an experienced incoming CEO. Management acknowledged recent underperformance and outlined concrete initiatives to restore growth and operational improvement.View all LFVN earnings summariesLFVN Stock 12 Month Forecast
Average Price Target
$5.00
▼(-26.04% Downside)
Technical Analysis
Ownership Overview
20.48% Insiders
8.54% Mutual Funds
0.11% Other Institutional Investors
64.47% Public Companies and
Individual Investors
Options Prices
Currently, No data available
---












